Friday, September 30, 2022


Biotechnology News Magazine

Controlant and Telit Partner on Global COVID-19 Vaccine Distribution Program & Win 2022 GLOMO Award

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

Controlant announced today it has successfully concluded the world’s single largest cellular IoT rollout for vaccine distribution using Telit modems for connectivity.

Telit is a global enabler of the Internet of Things (IoT), and Controlant is leader in real-time supply chain monitoring and visibility technologies for heavily regulated industries such as pharmaceuticals, life sciences, food and beverages.

In the battle against COVID-19, Controlant produced close to one million cellular cold-chain data logger devices, powered by Telit IoT modules, to secure the efficient distribution and the quality of billions of COVID-19 vaccine doses that one of the world’s premier biopharmaceutical companies is distributing across the globe.

“It’s been a roller coaster ride for the biopharmaceutical industry, racing first to come up with COVID-19 vaccines and then to distribute them safely. During a time of unprecedented disruptions in the global supply chain, Controlant produced nearly a million cellular cold-chain data logger devices, using Telit modems, to secure the efficient distribution and quality of billions of vaccine doses. Winning the GLOMO award is testament to the hard work of a great many people and to the strength of our partnership with Telit,” said Erlingur Brynjulfsson, CTO and co-founder, Controlant.

Controlant’s Cold Chain as a Service solution is a single source of supply chain truth. It is a powerful combination of IoT, advanced visibility and cost-reducing operational services that increase workflow efficiency and responsiveness while supporting quality and compliance efforts. COVID-19 vaccines, in particular, must maintain strict temperature control along every mile of the supply chain to ensure quality and integrity. Real-time supply chain monitoring solutions from Controlant offer complete visibility into shipping, distribution and warehousing, all of which reduce risk of spoilage, reducing product waste by more than 90 percent.

“Despite a period of severe material shortages and production challenges during various waves of virus outbreaks and regional lock-downs, Telit and its suppliers and production partners engaged in unprecedented collaboration to deliver all vaccine units in record time and enable the vaccination campaigns to be implemented without any disruption in the supply,” said Martin Krona, SVP, EMEA, Telit. “We are very pleased that our collaboration with Controlant’s R&D and product teams, employing Telit module technologies during a time of rapidly-changing cellular ecosystem and infrastructure, has been recognized by this award.”

The GLOMO Award was announced on March 2 during a virtual ceremony co-hosted by Sasha Twining and Justin Springham from Mobile World Live and streamed to audiences around the globe via LinkedIn. Telit and Controlant received the award for outstanding achievement in the category Best Innovation for COVID-19 Pandemic Response & Recovery.

“Congratulations to all of our 2022 GLOMO Award winners. The GLOMOs recognize the most innovative organizations in our ecosystem. The winners are changing how people, communities and businesses interact and evolve in a digital-first world,” said John Hoffman, CEO of GSMA Ltd. “This win affirms achievements of the highest merit, as judged by peers across the entire industry.”

The GLOMO Awards, chaired by Shaun Collins, Executive Chairman of CCS Insight, are adjudicated by over 200 independent industry experts, analysts, journalists, academics, mobile operator representatives, and CTOs; and are widely recognized as the most prestigious accolade in the mobile industry.


Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine